CMS advises Bruker on the acquisition of a majority stake in RECIPE
Frankfurt am Main – Bruker Corporation (NASDAQ: BRKR), a leading global manufacturer of scientific instruments and analytical and diagnostic solutions, has acquired a majority stake in Munich-based RECIPE Chemicals + Instruments GmbH, a provider of diagnostic assay kits for therapeutic drug monitoring. The aim of the majority investment is the further strategic positioning of Bruker in the field of clinical diagnostics.
A team headed by lead partner Dr Hendrik Hirsch and lead counsel Dr Berrit Roth-Mingram advised Bruker on all legal aspects of the transaction. The parties have agreed not to disclose further details of the transaction.
Bruker is a longstanding CMS client. The US company regularly relies on CMS's expertise for acquisitions and disposals. The current advice is further proof of the successful cooperation.
Press Contact
presse@cms-hs.com
